Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
ELOX
$15.27
+0.93%
ELOX
· Eloxx Pharmaceuticals, Inc.
$15.27
+0.14 (+0.93%)
At close · Oct 7
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 5, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$62.20M
Shares
4.04M
Volume · Oct 7
6309
Avg daily vol (3M)
47.21K
All webcasts
Earnings call · FY2020 Q4
Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2020 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Net income · derived Q4
-$6.13M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 11, 2021 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 12, 2021 · complete as-filed document